Theodorus

What is Theodorus?

Theodorus is a venture capital firm that operates as a spin-off fund of Universite Libre de Bruxelles. With a focus on seed and early-stage investment, the firm positions itself to maximize the value of research by helping outstanding researchers and entrepreneurs create innovative solutions and build disruptive companies.

Headquartered in Brussels, Belgium, and equipped with a regional office in Montreal, Canada, Theodorus specializes in sectors including biotech, med-tech, digital & engineering applications, life science, and mobile. Their reach extends to oncology ventures, underlining their commitment to cutting-edge science and technology companies. With 70 million euros under management, Theodorus supports not only state-of-the-art local research but also the global ambition of pioneering companies.

Over 17 years of operations, the firm has participated in approximately 40 investments, with an average multiple of 3, reflecting robust returns and successful exits. Case studies on their website, such as Euro Heat Pipes in the space thermal control systems sector and Ogeda in drug discovery, showcase their prowess in guiding companies to trade sales with industry leaders like Airbus Defence and Space and Astellas Pharma respectively.

Additionally, Theodorus works alongside partners to encourage investment in life sciences startups and scale-ups. For potential investors, the firm promises top-tier returns supported by their vast experience and strategic investments in transformative businesses.

In sum, Theodorus fuels the entrepreneurial ecosystem through sharp investment strategies, though they leverage their roots in a research university to nurture and support the commercialization of pioneering ideas into profitable and dynamic enterprises.